431 related articles for article (PubMed ID: 4454040)
21. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
Suba EA; Csako G
J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
[TBL] [Abstract][Full Text] [Related]
22. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
[TBL] [Abstract][Full Text] [Related]
23. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
24. Clq inhibition of the interaction of collagen with human platelets.
Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
[TBL] [Abstract][Full Text] [Related]
25. Superoxide, xanthine oxidase and platelet reactions: further studies on mechanisms by which oxidants influence platelets.
Levine PH; Sladdin DG; Krinsky NI
Thromb Haemost; 1981 Jun; 45(3):290-3. PubMed ID: 6269249
[TBL] [Abstract][Full Text] [Related]
26. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
McNicol A; Robson CA
J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-induced platelet secretion. Further evidence for a specific pathway.
Shuman MA; Botney M; Fenton JW
J Clin Invest; 1979 Jun; 63(6):1211-8. PubMed ID: 376555
[TBL] [Abstract][Full Text] [Related]
28. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin A1 inhibits increases in intracellular calcium concentration, TXA(2) production and platelet activation.
Zhu Y; Gu ZL; Liang ZQ; Zhang HL; Qin ZH
Acta Pharmacol Sin; 2006 May; 27(5):549-54. PubMed ID: 16626509
[TBL] [Abstract][Full Text] [Related]
30. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
31. Conditions influencing platelet lysis.
Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
[TBL] [Abstract][Full Text] [Related]
32. Effects of surface injury and shear stress on platelet aggregation and serotonin release.
Johnston GG; Marzec U; Berstein EF
Trans Am Soc Artif Intern Organs; 1975; 21():413-21. PubMed ID: 1146015
[No Abstract] [Full Text] [Related]
33. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
34. Extracts from Trifolium pallidum and Trifolium scabrum aerial parts as modulators of blood platelet adhesion and aggregation.
Kolodziejczyk-Czepas J; Olas B; Malinowska J; Wachowicz B; Szajwaj B; Kowalska I; Oleszek W; Stochmal A
Platelets; 2013; 24(2):136-44. PubMed ID: 22646735
[TBL] [Abstract][Full Text] [Related]
35. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
Matsuoka M; Watanabe T; Koike K; Sakuragawa N
Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899
[No Abstract] [Full Text] [Related]
36. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
Fernandes JB; Naik UP; Markell MS; Kornecki E
Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
[TBL] [Abstract][Full Text] [Related]
37. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
Geratz JD; Tidwell RR; Brinkhous KM; Mohammad SF; Dann O; Loewe H
Thromb Haemost; 1978 Apr; 39(2):411-25. PubMed ID: 580990
[TBL] [Abstract][Full Text] [Related]
39. Effect of neutral proteases from blood leukocytes on human platelets.
Bykowska K; Kaczanowska J; Karpowicz M; Stachurska J; Kopeć M
Thromb Haemost; 1983 Dec; 50(4):768-72. PubMed ID: 6320486
[TBL] [Abstract][Full Text] [Related]
40. [The role of adhesive proteins and membrane interactions in the processes of thrombocyte aggregation].
Belitser NV; Anishchuk MG; Pozdniakova TM; Gorkun OV; Veklich VI; Smekhova TR
Vestn Akad Med Nauk SSSR; 1991; (10):45-50. PubMed ID: 1801463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
